Prosecution Insights
Last updated: April 19, 2026

Examiner: GHAND, JENNIFER LEIGH-STEWAR

Tech Center 3700 • Art Units: 3762 3766 3791 3792 3796

This examiner grants 61% of resolved cases

Performance Statistics

60.6%
Allow Rate
-9.4% vs TC avg
732
Total Applications
+28.8%
Interview Lift
1489
Avg Prosecution Days
Based on 667 resolved cases, 2023–2026

Rejection Statute Breakdown

5.6%
§101 Eligibility
18.7%
§102 Novelty
39.3%
§103 Obviousness
28.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18288503 Handheld Auscultation Systems, Devices, and Methods Non-Final OA Emory University
18088019 FILTER FOR PARTICLES IN CATHETER PUMP SYSTEM Final Rejection TC1 LLC
17956754 APPARATUSES, SYSTEMS, AND METHODS OF IMPROVING PATCH PERFORMANCE FOR A MEDICAL DEVICE Non-Final OA DexCom, Inc.
17910784 SNARE FOR REMOVAL OF IMPLANTED CARDIAC LEADS Non-Final OA PHILIPS IMAGE GUIDED THERAPY CORPORATION
16743851 BIOLOGICAL INFORMATION MEASUREMENT SYSTEM Non-Final OA TOTO LTD.
16913040 OPTICAL SENSOR ASSEMBLY IN CATHETER-BASED MEDICAL DEVICES Final Rejection ABIOMED, Inc.
18099397 PERCUTANEOUS CIRCULATORY SUPPORT DEVICE INCLUDING GUIDEWIRE DISTAL TIP PORTION Non-Final OA Boston Scientific Scimed Inc.
18758623 MATERNAL MONITORING SYSTEMS AND METHODS Non-Final OA GE Precision Healthcare LLC
16318160 PATIENT MONITORING SYSTEM Non-Final OA KONINKLIJKE PHILIPS N.V.
17859647 SYSTEMS AND METHODS FOR ENHANCING INFECTION DETECTION AND MONITORING THROUGH DECOMPOSED PHYSIOLOGICAL DATA Non-Final OA THE REGENTS OF THE UNIVERSITY OF MICHIGAN
17915316 IMPLANTABLE MEDICAL DEVICE FOR DETECTING ATRIAL UNDERSENSING Final Rejection BIOTRONIK SE & Co. KG
16716304 MATCHING AND TRACKING TIME SEQUENCES OF HEART ACTIVATION Final Rejection BIOSENSE WEBSTER (ISRAEL) LTD.
18677774 METHOD AND APPARATUS FOR ATRIAL TACHYARRHYTHMIA DETECTION Non-Final OA Medtronic, Inc.
17816153 CLOSED LOOP CONTROL OF TIBIAL NERVE STIMULATION AND EFFICACY MONITORING Final Rejection Medtronic, Inc.
17447953 SYSTEMS AND METHODS FOR EMS DEVICE COMMUNICATIONS INTERFACE Non-Final OA ZOLL Medical Corporation
18104518 A Fully Differential Piezoelectric Microphone and Amplifier System for Cochlear Implants and Other Hearing Devices Non-Final OA The Trustees of Columbia University in the City of New York
18777924 ORAL SENSOR SYSTEM Non-Final OA Ivoclar Vivadent AG
18025761 BLOOD PUMP Non-Final OA Abiomed Europe GmbH
18201838 ELECTRODE ARRAY PACKAGING SYSTEM Non-Final OA Cochlear Limited
18754955 VETERINARY ACOUSTIC AND BIOFEEDBACK DEVICE Non-Final OA Quadralynx, Inc.
18165212 SUPPORT STRUCTURES FOR INTRAVASCULAR BLOOD PUMPS Final Rejection PROCYRION, INC.
18064559 CONNECTION SYSTEM FOR TRANSMITTING ENERGY AND/OR DATA FROM AND/OR TO AN IMPLANTABLE BLOOD PUMP, AND VENTRICULAR ASSIST DEVICE Non-Final OA Berlin Heart GmbH
18692757 ELECTRO-OPTICAL MECHANICALLY FLEXIBLE NEURAL PROBES Non-Final OA The Salk Institute for Biological Studies
18605386 SYSTEMS AND METHODS FOR TRANS-ESOPHAGEAL SYMPATHETIC GANGLION RECRUITMENT Non-Final OA Lungpacer Medical Inc.
17790776 LEAD CONDITION TESTING IN AN IMPLANTED CARDIAC DEVICE Non-Final OA Impulse Dynamics NV
16978283 SYSTEMS AND METHODS FOR OPERATING AN IMPLANTABLE MEDICAL DEVICE BASED UPON A SENSED PHYSICAL ACTION Non-Final OA INSPIRE MEDICAL SYSTEMS, INC.
17962469 Method and System For Generating An ECG Signal Non-Final OA Fraunhofer Gesellschaft zur Förderung der angewandten Forschung e.V.
17553176 DETECTION AND LOCALIZATION OF CARDIAC FAST FIRING Non-Final OA CARDIOINSIGHT TECHNOLOGIES INC.
18242198 UV THERAPY PROTOCOL FOR TREATMENT OF NON-DERMATOLOGICAL CHRONIC CONDITIONS Final Rejection Lumavive LLC
18199671 SYSTEM AND METHOD FOR PREVENTING GAS LEAKAGE FROM AN INTRA-AORTIC BALLOON Non-Final OA NuPulseCV, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month